ClearPoint Neuro adds to executive lineup ClearPoint Neuro said that Ernesto Salegio, PhD, will be joining its biologics and drug delivery team as vice president and segment leader for translational and preclinical research.Read More
Adagio antibodies protect against a range of coronaviruses Adagio Therapeutics is directing attention to newly published preclinical data showing that its ADG-2 antibody candidate offered strong potency against SARS-CoV-2, as well as a range of pre-emergent coronaviruses.Read More